All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY578 | Anti-NDUFA13 (6E1BH7) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Cattle, Human | 6E1BH7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY579 | Anti-NDUFA13 (1A8) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse | 1A8 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY580 | Anti-NDUFA13 (CBLG1-3087) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3087 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY581 | Anti-NDUFA13 (CBLG1-3232) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3232 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2218 | Anti-NDUFA13(6E1BH7) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Cattle, Human | 6E1BH7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2219 | Anti-NDUFA13(1A8) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse | 1A8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2220 | Anti-NDUFA13(CBLG1-3087) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3087 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2221 | Anti-NDUFA13(CBLG1-3232) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3232 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1288 | Anti-NDUFA13 (17D95) h(41BB-CD3ζ) CAR, pCDCAR1 | Bovine | 17D95 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1289 | Anti-NDUFA13 (CBWJN-0784) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJN-0784 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ3580 | Anti-NDUFA13 (17D95) h(CD28-CD3ζ) CAR, pCDCAR1 | Bovine | 17D95 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ3581 | Anti-NDUFA13 (CBWJN-0784) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJN-0784 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION